CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy
The companies hosted a joint webcast on May 23, 2023, to discuss the transaction.
T: (650) 446-7888
TSX Trust Company
301 – 100 Adelaide St W
Toronto, ON M5H 4H1
Marcum LLP
750 Third Ave
11th Floor
New York, NY 10017
Fenwick & West LLP
1191 Second Avenue
10th Floor
Seattle, WA 98101